TB vaccine trial launched in Gqeberha to address SA's number one killer disease

A global TB vaccine trial was launched THIS WEEK in Gqeberha to address South Africa's number one killer disease. The Wits Health Consortium announced the start of the Bill & Melinda Gates Medical Research Institute's Phase 3 clinical trial to assess the efficacy of TB vaccine candidate, The trial is being held at the Isango Lethemba TB Research Unit located at the Jose Pearson Hospital in Gqeberha. The Eastern Cape has the highest TB incidence in the country. For more Bongiwe Zwane spoke to Dr. Pauline Howell, TB research specialist from the Clinical HIV Research Institute...